Greehey Children's Cancer Research Institute

Producción científica

Producción científica por año 1988 2017 2019 2020 2021 2022 2023 2024 2025

• 95 Índice h
• 623 Article
• 45 Review article
• 20 Comment/debate
• 10 Letter
• 20 Más
  • 9 Chapter
  • 5 Editorial
  • 3 Conference contribution
  • 3 Short survey

Producción científica por año

Producción científica por año

Resultados de la búsqueda

• 2024

  Lessons learned from 20 years of preclinical testing in pediatric cancers

  Smith, M. A., Houghton, P. J., Lock, R. B., Maris, J. M., Gorlick, R., Kurmasheva, R. T., Li, X. N., Teicher, B. A., Chuang, J. H., Dela Cruz, F. S., Dyer, M. A., Kung, A. L., Lloyd, M. W., Mossé, Y. P., Stearns, T. M., Stewart, E. A., Bult, C. J. & Erickson, S. W., dic 2024, En: Pharmacology and Therapeutics. 264, 108742.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Antineoplastic Agent 100%
  1 Cita (Scopus)

• The history, landscape, and outlook of human cell line authentication and security

  Harbut, E., Makris, Y., Pertsemlidis, A. & Bleris, L., dic 2024, En: SLAS Discovery. 29, 8, 100194.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

• The Laws of Attraction: Chemokines as Critical Mediators in Cancer Progression and Immunotherapy Response in Bladder Cancer

  Hassouneh, Z., Kim, M. E., Bowman, N., Rao, M., Zhang, N., Huang, G., Svatek, R. S. & Mukherjee, N., oct 2024, En: Cancers. 16, 19, 3303.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Mediator 100%
  • Immunotherapy 100%
  • Chemokine 100%
  • Dynamics 22%
  • Immunocompetent Cell 22%

• The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects

  Do, C. T. P., Prochnau, J. Y., Dominguez, A., Wang, P. & Rao, M. K., sept 2024, En: Biomedicines. 12, 9, 1979.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Chemotherapy 100%
  • Pancreas Cancer 100%
  • Immunotherapy 100%
  • Tumor Microenvironment 100%
  • Immunosuppressive Agent 66%
  1 Cita (Scopus)

• The Versatile Attributes of MGMT: Its Repair Mechanism, Crosstalk with Other DNA Repair Pathways, and Its Role in Cancer

  Fang, Q., ene 2024, En: Cancers. 16, 2, 331.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Temozolomide 100%
  • Alkyl Group 100%
  9 Citas (Scopus)
• 2023

  Single-Cell Transcriptomics of Mtb/HIV Co-Infection

  Kulkarni, S., Endsley, J. J., Lai, Z., Bradley, T. & Sharan, R., sept 2023, En: Cells. 12, 18, 2295.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Human Immunodeficiency Virus 100%
  • Mixed Infection 100%
  • Transcriptomics 100%
  • Cells 100%
  • Coinfection 100%
  4 Citas (Scopus)

• Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action

  Worldwide Antimicrobial Resistance National/International Network Group (WARNING) Collaborators, dic 2023, En: World Journal of Emergency Surgery. 18, 1, 50.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Antimicrobial Resistance 100%
  • Antibiotics 100%
  • Antibiotic Agent 75%
  • Good Clinical Practice 33%
  • Antibiotic Therapy 33%
  14 Citas (Scopus)
• 2022

  An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma

  Shulman, D. S., Whittle, S. B., Surdez, D., Bailey, K. M., de Álava, E., Yustein, J. T., Shlien, A., Hayashi, M., Bishop, A. J. R., Crompton, B. D., DuBois, S. G., Shukla, N., Leavey, P. J., Lessnick, S. L., Kovar, H., Delattre, O., Grünewald, T. G. P., Antonescu, C. R., Roberts, R. D. & Toretsky, J. A. y 6 otros, Tirode, F., Gorlick, R., Janeway, K. A., Reed, D., Lawlor, E. R. & Grohar, P. J., dic 2022, En: npj Precision Oncology. 6, 1, 65.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Ewing Sarcoma 100%
  • Ewing's Sarcoma 100%
  • Patient 83%
  • Biological Marker 66%
  • Diseases 33%
  28 Citas (Scopus)

• Current Status of Epitranscriptomic Marks Affecting lncRNA Structures and Functions

  Miller, H. E., Ilieva, M., Bishop, A. J. R. & Uchida, S., abr 2022, En: Non-coding RNA. 8, 2, 23.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Long Non-Coding RNA 100%
  • Protein 66%
  • RNA 66%
  • Epitranscriptomics 50%
  • Coding 50%
  10 Citas (Scopus)

• Deep learning tackles single-cell analysis—a survey of deep learning for scRNA-seq analysis

  Flores, M., Liu, Z., Zhang, T., Hasib, M. M., Chiu, Y. C., Ye, Z., Paniagua, K., Jo, S., Zhang, J., Gao, S. J., Jin, Y. F., Chen, Y. & Huang, Y., ene 1 2022, En: Briefings in Bioinformatics. 23, 1, bbab531.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Deep Learning 100%
  • Survey 50%
  • Functions 33%
  • Autoencoder 33%
  • Profiling 16%
  37 Citas (Scopus)

• Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development

  Lv, Z., Cano, K. E., Jia, L., Drag, M., Huang, T. T. & Olsen, S. K., feb 3 2022, En: Frontiers in Chemistry. 9, 819165.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Proteinase 100%
  • Protease 100%
  • Severe Acute Respiratory Syndrome Coronavirus 2 88%
  • Antivirus Agent 33%
  • Papain 33%
  62 Citas (Scopus)
• 2021

  Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancers

  Janysek, D. C., Kim, J., Duijf, P. H. G. & Dray, E., mar 2021, En: Translational Oncology. 14, 3, 101012.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Cells 100%
  • Tumor Suppressor Protein 100%
  • Mutation 100%
  • Neoplasm 66%
  • Malignant Neoplasm 66%
  31 Citas (Scopus)

• Identifying clinical practice guidelines for symptom control in pediatric oncology

  Robinson, P. D., Tomlinson, D., Beauchemin, M., Gibson, P., Grimes, A., Dadzie, G., Safi, M., Vettese, E., Dupuis, L. L. & Sung, L., nov 2021, En: Supportive Care in Cancer. 29, 11, p. 7049-7055 7 p.

  Producción científica: Review article › revisión exhaustiva

  • Practice Guideline 100%
  • Symptom 47%
  • Child 23%
  • Systematic Review 23%
  • Symptom Management 23%
  10 Citas (Scopus)

• Prioritization of novel agents for patients with rhabdomyosarcoma: A report from the children’s oncology group (cog) new agents for rhabdomyosarcoma task force

  Pacenta, H. L., Allen-Rhoades, W., Langenau, D., Houghton, P. J., Keller, C., Heske, C. M., Deel, M. D., Linardic, C. M., Shern, J. F., Stewart, E., Turpin, B., Harrison, D. J., Khan, J., Mascarenhas, L., Skapek, S. X., Meyer, W. H., Hawkins, D. S., Chen, E. Y., Amatruda, J. F. & Hingorani, P. y 1 otros, Laetsch, T. W., abr 1 2021, En: Journal of Clinical Medicine. 10, 7, 1416.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Rhabdomyosarcoma 100%
  • Clinical Trial 80%
  • Patient 60%
  • Cytotoxic Agent 40%
  • Oncology 40%
  15 Citas (Scopus)

• Recent developments in nanomedicine for pediatric cancer

  Yang, S., Wallach, M., Krishna, A., Kurmasheva, R. & Sridhar, S., abr 1 2021, En: Journal of Clinical Medicine. 10, 7, 1437.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Chemotherapy 100%
  • Malignant Neoplasm 100%
  • Combination Therapy 75%
  • Child 75%
  • Pediatric Cancer 75%
  24 Citas (Scopus)

• Regulation of DNA duplication by the mTOR signaling pathway

  He, Z., Houghton, P. J., Williams, T. M. & Shen, C., 2021, En: Cell Cycle. 20, 8, p. 742-751 10 p.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Mechanistic Target of Rapamycin 100%
  • DNA 80%
  • Regulatory Mechanism 60%
  • Genetics 40%
  • Signal Transduction 20%
  11 Citas (Scopus)

• The Role of Human Centromeric RNA in Chromosome Stability

  Leclerc, S. & Kitagawa, K., mar 31 2021, En: Frontiers in Molecular Biosciences. 8, 642732.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • RNA 100%
  • Chromosome 50%
  • Chromosome Instability 50%
  • Satellite DNA 25%
  • Kinetochore 25%
  17 Citas (Scopus)
• 2020

  Mechanism and significance of chromosome damage repair by homologous recombination

  Kawale, A. S. & Sung, P., oct 2020, En: Essays in Biochemistry. 64, 5, p. 779-790 12 p.

  Producción científica: Review article › revisión exhaustiva

  • Homologous Recombination 100%
  • Chromosome Damage 25%
  • Mutation 12%
  • Nested Gene 12%
  • Aging 12%
  26 Citas (Scopus)

• Targeting RAS in pediatric cancer: Is it becoming a reality?

  Vaseva, A. V. & Yohe, M. E., feb 1 2020, En: Current Opinion in Pediatrics. 32, 1, p. 48-56 9 p.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Malignant Neoplasm 100%
  • Pediatric Cancer 100%
  • Cancer 66%
  • Clinical Trial 66%
  • Pediatrics 66%
  20 Citas (Scopus)

• The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication

  Tarsounas, M. & Sung, P., may 1 2020, En: Nature Reviews Molecular Cell Biology. 21, 5, p. 284-299 16 p.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • BRCA1 100%
  • Homologous Recombination 50%
  • DNA Repair 50%
  • DNA Replication 50%
  • Comprehension 50%
  212 Citas (Scopus)
• 2019

  Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children’s Oncology Group (COG) new agents for ewing sarcoma task force.

  Bailey, K., Cost, C., Davis, I., Glade-Bender, J., Grohar, P., Houghton, P., Isakoff, M., Stewart, E., Laack, N., Yustein, J., Reed, D., Janeway, K., Gorlick, R., Lessnick, S., DuBois, S. & Hingorani, P., 2019, En: F1000Research. 8, 493.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Ewing Sarcoma 100%
  • Patient 100%
  • Oncology 100%
  • Bone Cancer 40%
  • Diseases 20%
  57 Citas (Scopus)

• Guidelines for DNA recombination and repair studies: Mechanistic assays of DNA repair processes

  Klein, H. L., Ang, K. K. H., Arkin, M. R., Beckwitt, E. C., Chang, Y. H., Fan, J., Kwon, Y., Morten, M. J., Mukherjee, S., Pambos, O. J., Sayyed, H. E., Thrall, E. S., Vieira-Da-Rocha, J. P., Wang, Q., Wang, S., Yeh, H. Y., Biteen, J. S., Chi, P., Heyer, W. D. & Kapanidis, A. N. y 6 otros, Loparo, J. J., Strick, T. R., Sung, P., Van Houten, B., Niu, H. & Rothenberg, E., ene 2019, En: Microbial Cell. 6, 1, p. 65-101 37 p.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Mutagenesis 100%
  • DNA Repair 100%
  • Recombination Repair 100%
  • Molecule 50%
  • DNA Recombination 50%
  9 Citas (Scopus)

• Insights into pediatric rhabdomyosarcoma research: Challenges and goals

  Yohe, M. E., Heske, C. M., Stewart, E., Adamson, P. C., Ahmed, N., Antonescu, C. R., Chen, E., Collins, N., Ehrlich, A., Galindo, R. L., Gryder, B. E., Hahn, H., Hammond, S., Hatley, M. E., Hawkins, D. S., Hayes, M. N., Hayes-Jordan, A., Helman, L. J., Hettmer, S. & Ignatius, M. S. y 13 otros, Keller, C., Khan, J., Kirsch, D. G., Linardic, C. M., Lupo, P. J., Rota, R., Shern, J. F., Shipley, J., Sindiri, S., Tapscott, S. J., Vakoc, C. R., Wexler, L. H. & Langenau, D. M., oct 2019, En: Pediatric Blood and Cancer. 66, 10, e27869.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Rhabdomyosarcoma 100%
  • Clinical Trial 50%
  • Irinotecan 25%
  • Overall Survival 25%
  • Combination Therapy 25%
  59 Citas (Scopus)

• The BRCA tumor suppressor network in chromosome damage repair by homologous recombination

  Zhao, W., Wiese, C., Kwon, Y., Hromas, R. & Sung, P., jun 20 2019, En: Annual Review of Biochemistry. 88, p. 221-245 25 p.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Tumor Suppressor Protein 100%
  • Homologous Recombination 66%
  • Chromosome Damage 66%
  • Mutation 33%
  • Biological Functions 33%
  106 Citas (Scopus)
• 2018

  Cardiovascular disease in survivors of childhood cancer: Insights into epidemiology, pathophysiology, and prevention

  Armenian, S. H., Armstrong, G. T., Aune, G., Chow, E. J., Ehrhardt, M. J., Ky, B., Moslehi, J., Mulrooney, D. A., Nathan, P. C., Ryan, T. D., Van Der Pal, H. J., Van Dalen, E. C. & Kremer, L. C. M., jul 20 2018, En: Journal of Clinical Oncology. 36, 21, p. 2135-2144 10 p.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Cardiovascular Disease 100%
  • Therapeutic Procedure 71%
  • Childhood Cancer 42%
  • Cardiovascular Risk 28%
  • Pathophysiology 28%
  156 Citas (Scopus)

• The Children's Oncology Group Radiation Oncology Discipline: 15 Years of Contributions to the Treatment of Childhood Cancer

  Breneman, J. C., Donaldson, S. S., Constine, L., Merchant, T., Marcus, K., Paulino, A. C., Followill, D., Mahajan, A., Laack, N., Esiashvili, N., Haas-Kogan, D., Laurie, F., Olch, A., Ulin, K., Hodgson, D., Yock, T. I., Terezakis, S., Krasin, M., Panoff, J. & Chuba, P. y 7 otros, Hua, C. H., Hess, C. B., Houghton, P. J., Wolden, S., Buchsbaum, J., Fitzgerald, T. J. & Kalapurakal, J. A., jul 15 2018, En: International Journal of Radiation Oncology Biology Physics. 101, 4, p. 860-874 15 p.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Child 100%
  • Therapeutic Procedure 80%
  • Oncology 80%
  • Radiation Oncology 80%
  • Radiation Therapy 60%
  37 Citas (Scopus)
• 2016

  A review of new agents evaluated against pediatric acute lymphoblastic leukemia by the Pediatric Preclinical Testing Program

  Jones, L., Carol, H., Evans, K., Richmond, J., Houghton, P. J., Smith, M. A. & Lock, R. B., nov 1 2016, En: Leukemia. 30, 11, p. 2133-2141 9 p.

  Producción científica: Review article › revisión exhaustiva

  • Pediatrics 100%
  • Acute Lymphoblastic Leukemia 88%
  • Drug 44%
  • Chemotherapeutic Agent 44%
  • Clinical Trial 44%
  44 Citas (Scopus)

• Identifying novel therapeutic agents using xenograft models of pediatric cancer

  Kurmasheva, R. T. & Houghton, P. J., ago 1 2016, En: Cancer chemotherapy and pharmacology. 78, 2, p. 221-232 12 p.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Chemotherapy 100%
  • Combination Therapy 75%
  • Xenograft 50%
  • Childhood Cancer 50%
  • Cytotoxic Agent 50%
  14 Citas (Scopus)

• Preclinical models of childhood cancer for the development of targeted therapies

  Kurmasheva, R. T. & Houghton, P. J., feb 3 2016, En: Drug Discovery Today: Disease Models. 21, p. 3-9 7 p.

  Producción científica: Review article › revisión exhaustiva

  • Malignant Neoplasm 100%
  • Combination Therapy 100%
  • Childhood Cancer 100%
  • Development 100%
  • Cytotoxic Chemotherapy 100%
• 2015

  Computational challenges, tools, and resources for analyzing co- and post-transcriptional events in high throughput

  Bahrami-Samani, E., Vo, D. T., de Araujo, P. R., Vogel, C., Smith, A. D., Penalva, L. O. F. & Uren, P. J., may 1 2015, En: Wiley Interdisciplinary Reviews: RNA. 6, 3, p. 291-310 20 p.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • RNA 100%
  • High Throughput 75%
  • Events 75%
  • Profiling 50%
  • Procedure 50%
  12 Citas (Scopus)

• Preclinical childhood sarcoma models: Drug efficacy biomarker identification and validation

  Geier, B., Kurmashev, D., Kurmasheva, R. T. & Houghton, P. J., 2015, En: Frontiers in Oncology. 5, Aug, 193.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Neoplasm 100%
  • Biological Marker 100%
  • Malignant Neoplasm 100%
  • Osteosarcoma 50%
  • Morbidity 50%
  13 Citas (Scopus)
• 2014

  The tell-tale heart: Molecular and cellular responses to childhood anthracycline exposure

  Lindsey, M. L., Lange, R. A., Parsons, H., Andrews, T. & Aune, G. J., nov 15 2014, En: American Journal of Physiology - Heart and Circulatory Physiology. 307, 10, p. H1379-H1389

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Anthracycline 100%
  • Childhood 80%
  • Congestive Heart Failure 60%
  • Malignant Neoplasm 60%
  • Childhood Cancer 40%
  18 Citas (Scopus)
• 2013

  Translation regulation gets its 'omics' moment

  Kuersten, S., Radek, A., Vogel, C. & Penalva, L. O. F., nov 2013, En: Wiley Interdisciplinary Reviews: RNA. 4, 6, p. 617-630 14 p.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Protein 100%
  • RNA 100%
  • Ribosome 100%
  • Translation Regulation 50%
  • microRNA 50%
  42 Citas (Scopus)

• Using proteomics to uncover extracellular matrix interactions during cardiac remodeling

  Patterson, N. L., Iyer, R. P., de Castro Brás, L. E., Li, Y., Andrews, T. G., Aune, G. J., Lange, R. A. & Lindsey, M. L., ago 2013, En: Proteomics - Clinical Applications. 7, 7-8, p. 516-527 12 p.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • Proteomics 100%
  • Matrix Metalloproteinase 50%
  • Fibroblast 25%
  • Leukocytes 25%
  • Wound Healing 25%
  20 Citas (Scopus)
• 2012

  Before it gets started: Regulating translation at the 5′; UTR

  Araujo, P. R., Yoon, K., Ko, D., Smith, A. D., Qiao, M., Suresh, U., Burns, S. C. & Penalva, L. O. F., 2012, En: Comparative and Functional Genomics. 2012, 475731.

  Producción científica: Review article › revisión exhaustiva

  • Regulatory Mechanism 100%
  • RNA-binding Protein 66%
  • Translation Regulation 66%
  • Binding Protein 33%
  • Gene Expression 33%
  192 Citas (Scopus)

• MicroRNA regulation of cell viability and drug sensitivity in lung cancer

  Du, L. & Pertsemlidis, A., sept 2012, En: Expert Opinion on Biological Therapy. 12, 9, p. 1221-1239 19 p.

  Producción científica: Review article › revisión exhaustiva

  • microRNA 100%
  • Lung Cancer 77%
  • Drug 44%
  • Carcinogenesis 11%
  • Organisms 11%
  43 Citas (Scopus)
• 2009

  Global signatures of protein and mRNA expression levels

  De Sousa Abreu, R., Penalva, L. O., Marcotte, E. M. & Vogel, C., 2009, En: Molecular BioSystems. 5, 12, p. 1512-1526 15 p.

  Producción científica: Review article › revisión exhaustiva

  • mRNA Expression Level 100%
  • Protein Expression Level 100%
  • Protein Catabolism 25%
  • mRNA Stability 25%
  • Dosage Compensation 25%
  1028 Citas (Scopus)
• 2006

  Post-transcription meets post-genomic: The saga of RNA binding proteins in a new era

  Sanchez-Diaz, P. & Penalva, L. O. F., 2006, En: RNA biology. 3, 3, p. 101-109 9 p.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • RNA-binding Protein 100%
  • Post-Transcriptional Regulation 33%
  • Gene Expression 16%
  • RNA Translation 16%
  • RNA Splicing 16%
  57 Citas (Scopus)
• 2002

  RPA not that different from SSB

  Krejci, L. & Sung, P., 2002, En: Structure. 10, 5, p. 601-602 2 p.

  Producción científica: Review article › revisión exhaustiva

  Acceso abierto

  • DNA Binding 100%
  • Replication Protein A 100%
  • Introspection 100%
  • DNA 100%
  • Single-Stranded DNA 100%
  9 Citas (Scopus)
• 2000

  Efficacy of newer medications for treating depression in primary care patients

  Mulrow, C. D., Williams, J. W., Chiquette, E., Aguilar, C., Hitchcock-Noel, P., Lee, S., Cornell, J. & Stamm, K., ene 2000, En: American Journal of Medicine. 108, 1, p. 54-64 11 p.

  Producción científica: Review article › revisión exhaustiva

  • Placebo 100%
  • Patient 70%
  • Primary Health Care 60%
  • Antidepressant 60%
  • Treatment of Depression 60%
  116 Citas (Scopus)

• Garlic: effects on cardiovascular risks and disease, protective effects against cancer, and clinical adverse effects.

  Mulrow, C., Lawrence, V., Ackermann, R., Gilbert Ramirez, G., Morbidoni, L., Aguilar, C., Arterburn, J., Block, E., Chiquette, E., Gardener, C., Harris, M., Heidenreich, P., Mullins, D., Richardson, M., Russell, N., Vickers, A. & Young, V., oct 2000, En: Evidence report/technology assessment (Summary). 20, p. 1-4 4 p.

  Producción científica: Review article › revisión exhaustiva
  18 Citas (Scopus)

• Recombination factors of Saccharomyces cerevisiae

  Sung, P., Trujillo, K. M. & Van Komen, S., jun 30 2000, En: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 451, 1-2, p. 257-275 19 p.

  Producción científica: Review article › revisión exhaustiva

  • Saccharomyces cerevisiae 100%
  • Nested Gene 100%
  • Homologous Recombination 100%
  • RAD52 100%
  • Genetics 100%
  162 Citas (Scopus)
• 1999

  DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis

  Dasika, G. K., Lin, S. C. J., Zhao, S., Sung, P., Tomkinson, A. & Lee, E. Y. H. P., dic 20 1999, En: Oncogene. 18, 55, p. 7883-7899 17 p.

  Producción científica: Review article › revisión exhaustiva

  • Protein 100%
  • Yeast 33%
  • Mammalian Cell 33%
  • Gene Product 33%
  • DNA Damage 33%
  371 Citas (Scopus)

• Treatment of depression--newer pharmacotherapies.

  Mulrow, C. D., Williams, J. W., Trivedi, M., Chiquette, E., Aguilar, C., Cornell, J. E., Badgett, R., Noel, P. H., Lawrence, V., Lee, S., Luther, M., Ramirez, G., Richardson, W. S. & Stamm, K., mar 1999, En: Evidence report/technology assessment (Summary). 7, p. 1-4 4 p.

  Producción científica: Review article › revisión exhaustiva
  18 Citas (Scopus)
• 1998

  Evidence report on: Treatment of depression - Newer pharmacotherapies

  Mulrow, C. D., Williams, J., Trivedi, M., Chiquette, E., Aguilar, C., Cornell, J. E., Badgett, R., Hitchcock Noel, P., Lawrence, V., Lee, S., Luther, M., Ramirez, G., Richardson, W. S. & Stamm, K., 1998, En: Psychopharmacology bulletin. 34, 4, p. 409-795 387 p.

  Producción científica: Review article › revisión exhaustiva

  • Antidepressant 100%
  • Depression 62%
  • Patient 29%
  • Treatment 25%
  • Inpatient 22%
  47 Citas (Scopus)